Risk Models and Prognostic Factors

Robert Alter, MD comments on the use of prognostic models for determining risk status and informing treatment options in patients with RCC.

Related Videos
Expert on RCC
Experts on RCC
Experts on RCC
Experts on RCC
Experts on RCC
Experts on RCC
Data demonstrate the feasibility of automated glomerular filtration rate prediction to decide between partial nephrectomy and radical nephrectomy in kidney cancer, according to an expert from the Cleveland Clinic.
Experts on RCC
Experts on RCC
Early phase trials investigating cellular therapies, bispecific antibodies, and antibody-drug conjugates for refractory kidney cancer may uncover strategies to overcome resistance mechanisms.
Related Content